APT Medical (SHA:688617) estimated up to 104.5 million yuan in routine related-party transactions in 2026, according to a Wednesday filing with the Shanghai bourse.
About 61.5 million yuan will involve Mindray Bio-Medical Electronics, while 43.0 million yuan will involve other related entities, the filing said.
Shares of the medical device manufacturer rose 2% in recent trade.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments